Internal Medicine · Fremont, OH
NPI
1538165337
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
1223 Oak Harbor Rd
Fremont, OH, 43420
Phone (419) 334-7191
Groups this clinician bills Medicare through
Medicare paid, 2024
$251K
14,105 services
Medicare patients, 2024
265
Average age 77
Drug cost, 2024
$3.2M
13,771 prescriptions
Company payments, 2025
$5,617
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles L Valone Jr. was code J0897 (injection, denosumab, 1 mg), 1,980 times for 19 patients. In total Charles L Valone Jr. billed 14,105 services in 95 codes, and Medicare paid $251K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,980 | 19 | $20.36 | $40K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 708 | 80 | $0.68 | $481 |
| 99213 Office E&M - Established | Office | 583 | 161 | $52.33 | $31K |
| 99214 Office E&M - Established | Office | 454 | 150 | $77.23 | $35K |
| 36415 Venipuncture Blood Collection | Office | 338 | 146 | $4.89 | $1,652 |
| 99307 SNF E&M | Office | 184 | 54 | $23.38 | $4,302 |
| 99308 SNF E&M | Office | 171 | 65 | $45.68 | $7,812 |
| 99215 Office E&M - Established | Office | 132 | 78 | $107.49 | $14K |
| G0008 Administration of influenza virus vaccine | Office | 117 | 115 | $29.40 | $3,440 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 117 | 117 | $110.96 | $13K |
| 90673 Vaccine Product | Office | 115 | 115 | $81.82 | $9,409 |
| 93000 Electrocardiogram | Office | 114 | 100 | $7.98 | $910 |
| 99212 Office E&M - Established | Office | 114 | 75 | $32.68 | $3,726 |
| 20610 Joint Injection | Office | 74 | 25 | $38.84 | $2,875 |
| 83880 Clinical Chemistry | Office | 70 | 63 | $38.47 | $2,693 |
By year: 2022 $333K for 19,222 services; 2023 $318K for 19,910 services; 2024 $251K for 14,105 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 338 | 146 | $4.89 | $1,652 |
| 83880 Clinical Chemistry | 70 | 63 | $38.47 | $2,693 |
| 87804 Immunoassay | 32 | 15 | $16.22 | $519 |
| 87811 Immunoassay | 18 | 17 | $40.55 | $730 |
| 80061 Clinical Chemistry | 17 | 17 | $13.12 | $223 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles L Valone Jr. prescribed most often to Medicare patients was Montelukast Sodium, with 642 prescriptions and refills. In total Charles L Valone Jr. wrote 13,771 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 642 | 1,564 | 219 | $7,844 |
| Duloxetine Hcl Generic | 501 | 870 | 115 | $13K |
| Atorvastatin Calcium Generic | 418 | 845 | 115 | $4,868 |
| Rosuvastatin Calcium Generic | 385 | 1,013 | 111 | $6,525 |
| Levothyroxine Sodium Generic | 356 | 689 | 86 | $4,194 |
| Famotidine Generic | 343 | 767 | 102 | $4,338 |
| Acarbose Generic | 296 | 437 | 69 | $14K |
| Ezetimibe Generic | 275 | 652 | 104 | $6,639 |
| Carvedilol Generic | 273 | 556 | 67 | $3,063 |
| Eliquis Apixaban | 262 | 306 | 34 | $101K |
| Entresto Sacubitril/Valsartan | 261 | 384 | 39 | $183K |
| Metformin Hcl Generic | 242 | 521 | 74 | $2,311 |
| Spironolactone Generic | 241 | 451 | 69 | $3,527 |
| Omeprazole Generic | 200 | 424 | 59 | $2,529 |
| Trulicity Dulaglutide | 188 | 231 | 24 | $172K |
Brand drugs: 2,749 claims; generic drugs: 10,985 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles L Valone Jr. $5,617 ($5,617 in general payments such as food, travel and fees) from 31 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $956.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 19 | $956 |
| Abbvie Inc. ABBV | 19 | $728 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $690 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $568 |
| Novo Nordisk Inc NVO | 10 | $488 |
| Axsome Therapeutics, Inc. AXSM | 13 | $351 |
| Alkermes, Inc. ALKS | 4 | $263 |
| Harmony Biosciences LLC HRMY | 6 | $216 |
| Ardelyx, Inc. ARDX | 4 | $183 |
| Lilly USA, LLC LLY | 14 | $167 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.